ajantapharma.com · 786
Ajanta Pharma Limited is a renowned pharmaceutical company with a strong focus on superior formulation development capabilities and bringing many 1st to market products. With a global business presence, Ajanta Pharma is known for its clear strategy, consistent performance, and differentiated smart product portfolio. The company's commitment to research and development gives them the innovation edge, while their manufacturing facilities ensure the production of quality products. Ajanta Pharma operates in various business areas including India (branded generics), emerging markets (branded generics), USA (generics), and Africa (institution business). The company also places high importance on corporate governance, investor relations, media engagement, and social responsibility through their CSR initiatives.
ajantapharma.com · years statistic
2000
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 1 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2001
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2002
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 2 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 3 |
| 10 | 0 |
| 11 | 2 |
| 12 | 0 |
2003
| 1 | 0 |
| 2 | 4 |
| 3 | 2 |
| 4 | 1 |
| 5 | 1 |
| 6 | 3 |
| 7 | 1 |
| 8 | 2 |
| 9 | 1 |
| 10 | 3 |
| 11 | 0 |
| 12 | 4 |
2004
| 1 | 0 |
| 2 | 1 |
| 3 | 2 |
| 4 | 0 |
| 5 | 2 |
| 6 | 9 |
| 7 | 2 |
| 8 | 1 |
| 9 | 3 |
| 10 | 3 |
| 11 | 2 |
| 12 | 1 |
2005
| 1 | 1 |
| 2 | 2 |
| 3 | 2 |
| 4 | 1 |
| 5 | 2 |
| 6 | 0 |
| 7 | 1 |
| 8 | 2 |
| 9 | 0 |
| 10 | 0 |
| 11 | 1 |
| 12 | 4 |
2006
| 1 | 1 |
| 2 | 5 |
| 3 | 6 |
| 4 | 8 |
| 5 | 6 |
| 6 | 2 |
| 7 | 1 |
| 8 | 7 |
| 9 | 0 |
| 10 | 3 |
| 11 | 0 |
| 12 | 5 |
2007
| 1 | 6 |
| 2 | 2 |
| 3 | 2 |
| 4 | 2 |
| 5 | 3 |
| 6 | 2 |
| 7 | 0 |
| 8 | 0 |
| 9 | 4 |
| 10 | 7 |
| 11 | 1 |
| 12 | 0 |
2008
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 1 |
| 10 | 2 |
| 11 | 0 |
| 12 | 2 |
2009
| 1 | 1 |
| 2 | 1 |
| 3 | 1 |
| 4 | 2 |
| 5 | 2 |
| 6 | 1 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 1 |
| 11 | 2 |
| 12 | 1 |
2010
| 1 | 1 |
| 2 | 1 |
| 3 | 2 |
| 4 | 3 |
| 5 | 1 |
| 6 | 2 |
| 7 | 3 |
| 8 | 1 |
| 9 | 2 |
| 10 | 4 |
| 11 | 4 |
| 12 | 4 |
2011
| 1 | 2 |
| 2 | 5 |
| 3 | 1 |
| 4 | 3 |
| 5 | 3 |
| 6 | 3 |
| 7 | 3 |
| 8 | 2 |
| 9 | 3 |
| 10 | 5 |
| 11 | 3 |
| 12 | 1 |
2012
| 1 | 9 |
| 2 | 1 |
| 3 | 3 |
| 4 | 1 |
| 5 | 5 |
| 6 | 1 |
| 7 | 2 |
| 8 | 3 |
| 9 | 21 |
| 10 | 4 |
| 11 | 1 |
| 12 | 2 |
2013
| 1 | 5 |
| 2 | 2 |
| 3 | 3 |
| 4 | 1 |
| 5 | 3 |
| 6 | 1 |
| 7 | 3 |
| 8 | 1 |
| 9 | 2 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2014
| 1 | 2 |
| 2 | 2 |
| 3 | 2 |
| 4 | 3 |
| 5 | 2 |
| 6 | 4 |
| 7 | 2 |
| 8 | 2 |
| 9 | 0 |
| 10 | 2 |
| 11 | 1 |
| 12 | 3 |
2015
| 1 | 1 |
| 2 | 3 |
| 3 | 2 |
| 4 | 3 |
| 5 | 2 |
| 6 | 1 |
| 7 | 2 |
| 8 | 4 |
| 9 | 3 |
| 10 | 1 |
| 11 | 3 |
| 12 | 2 |
2016
| 1 | 6 |
| 2 | 2 |
| 3 | 6 |
| 4 | 1 |
| 5 | 3 |
| 6 | 2 |
| 7 | 3 |
| 8 | 3 |
| 9 | 4 |
| 10 | 7 |
| 11 | 3 |
| 12 | 1 |
2017
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 4 |
| 6 | 7 |
| 7 | 4 |
| 8 | 4 |
| 9 | 5 |
| 10 | 5 |
| 11 | 3 |
| 12 | 4 |
2018
| 1 | 4 |
| 2 | 5 |
| 3 | 4 |
| 4 | 4 |
| 5 | 3 |
| 6 | 5 |
| 7 | 3 |
| 8 | 6 |
| 9 | 3 |
| 10 | 5 |
| 11 | 3 |
| 12 | 4 |
2019
| 1 | 2 |
| 2 | 4 |
| 3 | 4 |
| 4 | 4 |
| 5 | 5 |
| 6 | 6 |
| 7 | 2 |
| 8 | 2 |
| 9 | 6 |
| 10 | 3 |
| 11 | 3 |
| 12 | 3 |
2020
| 1 | 2 |
| 2 | 4 |
| 3 | 2 |
| 4 | 2 |
| 5 | 5 |
| 6 | 4 |
| 7 | 4 |
| 8 | 7 |
| 9 | 3 |
| 10 | 2 |
| 11 | 4 |
| 12 | 5 |
2021
| 1 | 1 |
| 2 | 2 |
| 3 | 1 |
| 4 | 1 |
| 5 | 4 |
| 6 | 9 |
| 7 | 3 |
| 8 | 4 |
| 9 | 1 |
| 10 | 8 |
| 11 | 10 |
| 12 | 10 |
2022
| 1 | 10 |
| 2 | 2 |
| 3 | 13 |
| 4 | 7 |
| 5 | 5 |
| 6 | 5 |
| 7 | 4 |
| 8 | 4 |
| 9 | 5 |
| 10 | 6 |
| 11 | 6 |
| 12 | 2 |
2023
| 1 | 7 |
| 2 | 12 |
| 3 | 14 |
| 4 | 5 |
| 5 | 5 |
| 6 | 20 |
| 7 | 1 |
| 8 | 11 |
| 9 | 3 |
| 10 | 3 |
| 11 | 1 |
| 12 | 1 |
2024
| 1 | 2 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
